Abstract
Previous studies have indicated that iron disorder, inflammation, and autophagy play an important role in traumatic brain injury (TBI). The triggering receptor expressed on myeloid cells 2 (TREM2), an immunoglobulin superfamily transmembrane receptor, is involved in inflammation. However, the role of TREM2 in modulating the microglia response in TBI has been rarely investigated. The present study aimed to investigate if the iron chelator deferoxamine (DFO) could ameliorate TBI through autophagy mediated by the TREM2. TBI was developed by the controlled cortical impact (CCI) mouse model and stretching of individual primary cortical microglia taken from the tissue of the rat brain. DFO was intraperitoneally used for intervention. Western blotting assay, qRT-PCR, TUNEL staining, immunofluorescence staining, confocal microscopy analysis, transmission electron microscopy, H&E staining, brain water content measurement, and the neurobehavioral assessments were performed. TREM2 expression was up-regulated in cortex of TBI mice model and in microglia stretching model, which was attenuated by DFO. After the mice were subjected to CCI, DFO treatment significantly up-regulated the protein levels of autophagy compared with the TBI group at 3 days and caused an increase of autophagic vacuoles. Treatment with DFO reduced TBI-induced cell apoptosis, cerebral edema, neuroinflammation, and motor function impairment in mice, at least partly via the mTOR signaling pathway that facilitates the TREM2 activity. The results indicated that the maintenance of iron homeostasis by DFO plays neuroprotection by modulating the inflammatory response to TBI through TREM2-mediated autophagy. This study suggested that TREM2-mediated autophagy might be a potential target for therapeutic intervention in TBI.
Similar content being viewed by others
Data availability
The data that support the findings of this study are available on request from the corresponding author.
Abbreviations
- CNS:
-
Central nervous system
- CCI:
-
Controlled cortical impact
- DPI:
-
Days post-injury
- DFO:
-
Deferoxamine
- Iba-1:
-
Ionized calcium-binding adaptor molecule 1
- IL-1β:
-
Interleukin-1 beta
- IL-4:
-
Interleukin-4
- IL-6:
-
Interleukin-6
- mTOR:
-
Mammalian target of rapamycin
- mNSS:
-
Modified neurological severity scores
- qRT-PCR:
-
Quantitative real-time polymerase chain reaction
- SI:
-
Stretch injury
- TUNEL:
-
TdT-mediated dUTP nick end labeling
- TBI:
-
Traumatic brain injury
- TREM2:
-
Triggering receptor expressed on myeloid cells 2
- TNF-α:
-
Tumor necrosis factor-alpha
References
Wilson L, Stewart W, Dams-O’Connor K, Diaz-Arrastia R, Horton L, Menon DK, Polinder S (2017) The chronic and evolving neurological consequences of traumatic brain injury. Lancet Neurol 16(10):813–825. https://doi.org/10.1016/s1474-4422(17)30279-x
Barnes DE, Byers AL, Gardner RC, Seal KH, Boscardin WJ, Yaffe K (2018) Association of mild traumatic brain injury with and without loss of consciousness with dementia in US military veterans. JAMA Neurol 75(9):1055–1061. https://doi.org/10.1001/jamaneurol.2018.0815
Jiang JY, Gao GY, Feng JF, Mao Q, Chen LG, Yang XF, Liu JF, Wang YH et al (2019) Traumatic brain injury in China. Lancet Neurol 18(3):286–295. https://doi.org/10.1016/s1474-4422(18)30469-1
Blennow K, Brody DL, Kochanek PM, Levin H, McKee A, Ribbers GM, Yaffe K, Zetterberg H (2016) Traumatic brain injuries. Nat Rev Dis Primers 2:16084. https://doi.org/10.1038/nrdp.2016.84
Morganti-Kossmann MC, Semple BD, Hellewell SC, Bye N, Ziebell JM (2019) The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments. Acta Neuropathol 137(5):731–755. https://doi.org/10.1007/s00401-018-1944-6
Corps KN, Roth TL, McGavern DB (2015) Inflammation and neuroprotection in traumatic brain injury. JAMA Neurol 72(3):355–362. https://doi.org/10.1001/jamaneurol.2014.3558
Wu J, Lipinski MM (2019) Autophagy in neurotrauma: good, bad, or dysregulated. Cells 8(7). https://doi.org/10.3390/cells8070693
Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y et al (2017) TREM2 maintains microglial metabolic fitness in Alzheimer’s disease. Cell 170(4):649-663.e613. https://doi.org/10.1016/j.cell.2017.07.023
Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179(2):292–311. https://doi.org/10.1016/j.cell.2019.08.053
Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, Gentleman S, Heckemann RA et al (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 70(3):374–383. https://doi.org/10.1002/ana.22455
Chen X, Wang H, Zhou M, Li X, Fang Z, Gao H, Li Y, Hu W (2018) Valproic acid attenuates traumatic brain injury-induced inflammation in vivo: involvement of autophagy and the Nrf2/ARE signaling pathway. Front Mol Neurosci 11:117. https://doi.org/10.3389/fnmol.2018.00117
Ulland TK, Colonna M (2018) TREM2 - a key player in microglial biology and Alzheimer disease. Nat Rev Neurol 14(11):667–675. https://doi.org/10.1038/s41582-018-0072-1
Deczkowska A, Weiner A, Amit I (2020) The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell 181(6):1207–1217. https://doi.org/10.1016/j.cell.2020.05.003
Saber M, Kokiko-Cochran O, Puntambekar SS, Lathia JD, Lamb BT (2017) Triggering receptor expressed on myeloid cells 2 deficiency alters acute macrophage distribution and improves recovery after traumatic brain injury. J Neurotrauma 34(2):423–435. https://doi.org/10.1089/neu.2016.4401
Robicsek SA, Bhattacharya A, Rabai F, Shukla K, Doré S (2020) Blood-related toxicity after traumatic brain injury: potential targets for neuroprotection. Mol Neurobiol 57(1):159–178. https://doi.org/10.1007/s12035-019-01766-8
Saletti PG, Ali I, Casillas-Espinosa PM, Semple BD, Lisgaras CP, Moshé SL, Galanopoulou AS (2019) In search of antiepileptogenic treatments for post-traumatic epilepsy. Neurobiol Dis 123:86–99. https://doi.org/10.1016/j.nbd.2018.06.017
Wu Y, Li X, Xie W, Jankovic J, Le W, Pan T (2010) Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int 57(3):198–205. https://doi.org/10.1016/j.neuint.2010.05.008
Cappellini MD, Pattoneri P (2009) Oral iron chelators. Annu Rev Med 60:25–38. https://doi.org/10.1146/annurev.med.60.041807.123243
Wang K, Jing Y, Xu C, Zhao J, Gong Q, Chen S (2020) HIF-1α and VEGF are involved in deferoxamine-ameliorated traumatic brain injury. J Surg Res 246:419–426. https://doi.org/10.1016/j.jss.2019.09.023
Sawant-Pokam PA, Vail TJ, Metcalf CS, Maguire JL, McKean TO, McKean NO, Brennan KC (2020) Preventing neuronal edema increases network excitability after traumatic brain injury. J Clin Invest 130(11):6005–6020. https://doi.org/10.1172/jci134793
Tarudji AW, Gee CC, Romereim SM, Convertine AJ, Kievit FM (2021) Antioxidant thioether core-crosslinked nanoparticles prevent the bilateral spread of secondary injury to protect spatial learning and memory in a controlled cortical impact mouse model of traumatic brain injury. Biomaterials 272:120766. https://doi.org/10.1016/j.biomaterials.2021.120766
Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G (2004) Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg 100(4):672–678. https://doi.org/10.3171/jns.2004.100.4.0672
Zhang L, Hu R, Li M, Li F, Meng H, Zhu G, Lin J, Feng H (2013) Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury. Neurol Sci 34(5):639–645. https://doi.org/10.1007/s10072-012-1090-1
Siao CJ, Tsirka SE (2002) Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 22(9):3352–3358. https://doi.org/10.1523/jneurosci.22-09-03352.2002
Rathnasamy G, Ling EA, Kaur C (2011) Iron and iron regulatory proteins in amoeboid microglial cells are linked to oligodendrocyte death in hypoxic neonatal rat periventricular white matter through production of proinflammatory cytokines and reactive oxygen/nitrogen species. J Neurosci 31(49):17982–17995. https://doi.org/10.1523/jneurosci.2250-11.2011
Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J, Chopp M (2001) Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32(11):2682–2688. https://doi.org/10.1161/hs1101.098367
Wu H, Zheng J, Xu S, Fang Y, Wu Y, Zeng J, Shao A, Shi L et al (2021) Mer regulates microglial/macrophage M1/M2 polarization and alleviates neuroinflammation following traumatic brain injury. J Neuroinflammation 18(1):2. https://doi.org/10.1186/s12974-020-02041-7
Kumar A, Stoica BA, Loane DJ, Yang M, Abulwerdi G, Khan N, Kumar A, Thom SR et al (2017) Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury. J Neuroinflammation 14(1):47. https://doi.org/10.1186/s12974-017-0819-4
Vázquez-Rosa E, Shin MK, Dhar M, Chaubey K, Cintrón-Pérez CJ, Tang X, Liao X, Miller E et al (2020) P7C3-A20 treatment one year after TBI in mice repairs the blood-brain barrier, arrests chronic neurodegeneration, and restores cognition. Proc Natl Acad Sci U S A 117(44):27667–27675. https://doi.org/10.1073/pnas.2010430117
Mu X, He H, Wang J, Long W, Li Q, Liu H, Gao Y, Ouyang L et al (2019) Carbogenic nanozyme with ultrahigh reactive nitrogen species selectivity for traumatic brain injury. Nano Lett 19(7):4527–4534. https://doi.org/10.1021/acs.nanolett.9b01333
Loane DJ, Kumar A (2016) Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol 275 Pt 3 (0 3):316–327. https://doi.org/10.1016/j.expneurol.2015.08.018
Perugorria MJ, Esparza-Baquer A, Oakley F, Labiano I, Korosec A, Jais A, Mann J, Tiniakos D et al (2019) Non-parenchymal TREM-2 protects the liver from immune-mediated hepatocellular damage. Gut 68(3):533–546. https://doi.org/10.1136/gutjnl-2017-314107
Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M (2006) Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 177(6):3520–3524. https://doi.org/10.4049/jimmunol.177.6.3520
Zhao J, Xu C, Cao H, Zhang L, Wang X, Chen S (2019) Identification of target genes in neuroinflammation and neurodegeneration after traumatic brain injury in rats. PeerJ 7:e8324. https://doi.org/10.7717/peerj.8324
Viscomi MT, D’Amelio M, Cavallucci V, Latini L, Bisicchia E, Nazio F, Fanelli F, Maccarrone M et al (2012) Stimulation of autophagy by rapamycin protects neurons from remote degeneration after acute focal brain damage. Autophagy 8(2):222–235. https://doi.org/10.4161/auto.8.2.18599
Zhang F, Dong H, Lv T, Jin K, Jin Y, Zhang X, Jiang J (2018) Moderate hypothermia inhibits microglial activation after traumatic brain injury by modulating autophagy/apoptosis and the MyD88-dependent TLR4 signaling pathway. J Neuroinflammation 15(1):273. https://doi.org/10.1186/s12974-018-1315-1
Yoshii SR, Mizushima N (2017) Monitoring and measuring autophagy. Int J Mol Sci 18(9). https://doi.org/10.3390/ijms18091865
Matsuzawa-Ishimoto Y, Hwang S, Cadwell K (2018) Autophagy and inflammation. Annu Rev Immunol 36:73–101. https://doi.org/10.1146/annurev-immunol-042617-053253
Erlich S, Alexandrovich A, Shohami E, Pinkas-Kramarski R (2007) Rapamycin is a neuroprotective treatment for traumatic brain injury. Neurobiol Dis 26(1):86–93. https://doi.org/10.1016/j.nbd.2006.12.003
Cheng H, Wang N, Ma X, Wang P, Dong W, Chen Z, Wu M, Wang Z et al (2022) Spatial-temporal changes of iron deposition and iron metabolism after traumatic brain injury in mice. Front Mol Neurosci 15:949573. https://doi.org/10.3389/fnmol.2022.949573
Tang S, Gao P, Chen H, Zhou X, Ou Y, He Y (2020) The role of iron, its metabolism and ferroptosis in traumatic brain injury. Front Cell Neurosci 14:590789. https://doi.org/10.3389/fncel.2020.590789
Funding
This work was supported by the Science and Technology Commission of Shanghai Municipality under the Natural Science Foundation of Shanghai [19ZR1438600 and 21142202100].
Author information
Authors and Affiliations
Contributions
Chen, SW conceived of the research and revised the manuscript. Zhang, CH and Xu, C performed the experiments and collected the data. Cao, HL, Jing, Y, and Wang, XY were responsible for the data analysis. Zhao, JW and Gong, QY prepared materials. Zhang, CH and Xu, C wrote the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the Animal Ethics Committee of the Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine for the care and use of experimental animals.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, C., Xu, C., Jing, Y. et al. Deferoxamine Induces Autophagy Following Traumatic Brain Injury via TREM2 on Microglia. Mol Neurobiol (2023). https://doi.org/10.1007/s12035-023-03875-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12035-023-03875-x